Sort
15,440 grants matching “organoids”
Sex steroid signaling and adaptive growth of the intestine
$472,704Bruce A Edgar · University Of Utah · R01 · FY2023 · DK
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
$472,698Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA
Coordinated regulation of alternative pre-mRNA processing in colon cancer
$472,634Klemens J Hertel · University Of California-Irvine · R01 · FY2015 · CA
Induction and Evolution of Metaplasia in the Stomach
$472,614James R Goldenring · Vanderbilt University Medical Center · R01 · FY2020 · DK
DEVELOPMENTAL FUNDS (Core-002)
$472,600Beverly Shriver Mitchell · Stanford University · P30 · FY2019 · CA
Epigenetic dysregulation in APC-negative colorectal cancer
$472,530Nathan A. Ellis · University Of Arizona · R01 · FY2023 · CA
Functional consequences of mutations in spliceosomal small nuclear RNAs
$472,491Richard A Padgett · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · GM
Preclinical and clinical characterization of DNMT inhibitors +/- standard chemoimmunotherapy in TNBC
$472,447Liewei Wang · Mayo Clinic Rochester · R01 · FY2025 · CA
3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma
$472,438Daniel Pelaez · University Of Miami School Of Medicine · R01 · FY2022 · CA
3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury
$472,298Ann M Parr · University Of Minnesota · R01 · FY2024 · NS
Core 3: Mouse Models Core (MM Core)
$472,258Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2024 · CA
Novel Approaches for Improving Inflammation Resolution Following Chronic Exposure to Air Pollutants
$472,252Srinivasa Reddy · University Of California Los Angeles · R01 · FY2023 · ES
The Evolution of Sarcoma Drug Sensitivity through Time and Space
$472,053Alice Soragni · University Of California Los Angeles · R01 · FY2024 · CA
Variant-to-gene mapping for brain related traits and disorders
$471,924Alessandra Chesi · University Of Pennsylvania · R35 · FY2023 · HG
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$471,860Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2025 · DK
Network modulation to improve gene therapy in CLN3 disease
$471,780Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · R56 · FY2022 · NS
Stem Cell-Based Models for Elucidating Human Adrenocortical Development and Dysfunction
$471,752Kotaro Sasaki · University Of Pennsylvania · R01 · FY2024 · DK
Targeting oncogenic dopamine receptor signaling in glioblastoma
$471,662Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Targeting oncogenic dopamine receptor signaling in glioblastoma
$471,662Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$471,647Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Role of the renal organic anion transporter OAT1 in metabolism and physiology
$471,623Sanjay K Nigam · University Of California, San Diego · R01 · FY2019 · GM
The selective advantage of mismatch repair loss in colonic stem cells
$471,589Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · CA
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$471,586Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$471,586Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Role of Intestinal Autophagy in the Pathogenesis of Alcohol Associated Liver Disease
$471,559Paul Gideon Thomes · Auburn University At Auburn · R01 · FY2025 · AA